810106C

NBD AA

Avanti Research^™ - A Croda Brand 810106C

• 別名: 20-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino] arachidonic acid
• 実験式（ヒル表記法）: C₂₆H₃₄ N₄O₅
• CAS番号: 2254005-15-5
• 分子量: 482.57
• UNSPSCコード: 12352211
• NACRES: NA.25

特性

• アッセイ: >99% (TLC)
• 形状: liquid
• 包装: pkg of 1 × 1 mL (810106C-1mg)
• メーカー／製品名: Avanti Research^™ - A Croda Brand 810106C
• 濃度: 1 mg/mL (810106C-1mg)
• 脂質タイプ: fluorescent lipids; bioactive lipids
• 輸送温度: dry ice
• 保管温度: −70°C

詳細

詳細

The endocannabinoid pathway influences behavior, lipogenesis, embryologic development, and pathophysiological effects including pain, inflammation, stress, obesity, and non-alcoholic fatty liver disease. Endogenous endocannabinoids including arachidonoylethanolamide (anandamide, AEA) and 2-arachidonoylglycerol (2-AG) are derived from arachidonic acid (AA). Fluorescent NBD-AA and NBD-AEA analogues are direct probes that can be used for visualizing the uptake, intracellular trafficking, and targeting of these molecules by living cells, as well as measuring the binding of endocannabinoids to cytosolic binding proteins. Importantly, direct binding studies show the affinities of the fluorescent analogues are in the same range as the respective unlabeled ligands. Fluorescent endocannabinoid probes are useful for mapping the impact of various treatments, inhibitors, etc on endocannabinoid uptake and distribution in living cells.

包装

5 mL Amber Glass Screw Cap Vial/Argon/Foil Bag 810106C-1mg)

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全性情報

• ピクトグラム: GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H302,H315,H319,H331,H336,H351,H361d,H372
• 注意書き: P260 - P280 - P301 + P312 + P330 - P304 + P340 + P311 - P305 + P351 + P338 - P403 + P233
• 危険有害性の分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• ターゲットの組織: Central nervous system
• WGK: WGK 3